ALTEOGEN Inc. (KOSDAQ:196170)
South Korea · Delayed Price · Currency is KRW 518,000
+47,500 (10.10%)
At close: Jan 16, 2026
ALTEOGEN Market Cap
ALTEOGEN has a market cap or net worth of 27.7 trillion as of January 16, 2026. Its market cap has increased by 72.41% in one year.
Market Cap
27.70T
Enterprise Value
27.46T
Revenue
202.18B
Ranking
n/a
PE Ratio
228.90
Stock Price
518,000.00
Market Cap Chart
Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 27.70T, an increase of 22,994.97%. That is a compound annual growth rate of 63.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 27.70T | 15.24% |
| Dec 30, 2025 | 24.04T | 45.74% |
| Dec 30, 2024 | 16.49T | 221.05% |
| Dec 28, 2023 | 5.14T | 160.78% |
| Dec 29, 2022 | 1.97T | -38.41% |
| Dec 30, 2021 | 3.20T | -36.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 89.20T |
| Celltrion | 46.28T |
| ABL Bio | 10.62T |
| SK Biopharmaceuticals | 9.51T |
| Yuhan | 8.15T |
| HLB Co., Ltd. | 6.91T |
| LigaChem Biosciences | 5.93T |
| Sam Chun Dang Pharm. | 5.85T |